The Prevention Of New Progress In The Treatment Of Cerebral Stroke With Nonvalvular Atrial Fibrillation

Atrial fibrillation is the most common arrhythmia in clinic,and easily leads to stroke,which has high mortality and morbidity.In recent years,we have already attached great importance to the prevention of stroke in patients with atrial fibrillation, but the effect was not obvious.The gold standard in preventing stroke has been oral warfarin, while the narrow therapeutic window that leads to frequent monitoring of international normalized ratio(INR) has reduced the patients compliance.New oral anticoagulants(NOAC) make up for the inadequacy of warfarin, but not all patients can be tolerated or effective.For these patients, the percutaneous left atrial appendage occlusion has brought us new hope. This paper reviews the therapeutic advances of preventing the stroke in patients with atrial fibrillation.